Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10222947 | Surgery | 2018 | 6 Pages |
Abstract
A large proportion of patients with residual positron emission tomography-avidity after first-line chemotherapy of mediastinal lymphomas have residual disease that can be detected safely using minimally invasive thoracoscopy.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Liam BS, Hatice MD, Malcolm M. MD, Ankit MD,